Market Place
Sourcing Support
All News #Library
Others
Lisata Pharma Terminates Certepetide License Agreement With Qilu
27 Jan 2026 //
GLOBENEWSWIRE
Sagent, Qilu Team up To Broaden Access to Injectables in U.S
08 Jul 2025 //
PR NEWSWIRE
Mabwell License Agreement Albipagrastim to Qilu Pharmaceutical
27 Jun 2025 //
PR NEWSWIRE
Qilu Pharma Showcases QL1706 Clinical Trial Outcomes in Oral Presentation
15 Mar 2024 //
PR NEWSWIRE
Results from Trial of Qilu`s Anticancer Agent QL1706 Featured in Presentation
04 Mar 2024 //
PR NEWSWIRE
Results of Phase II Study on Qilu Pharmaceutical`s Novel Drug QL1706 Published
02 Feb 2024 //
PR NEWSWIRE
Results of the Phase III Study on Qilu Pharmaceutical`s Iruplinalkib Published
30 Jan 2024 //
PR NEWSWIRE
Qilu Pharmaceutical Announces Results from Phase I Clinical Study for QLS31905
11 Dec 2023 //
PR NEWSWIRE
QiLu Pharmaceutical`s Iruplinalkib Phase III Study Researched Primary Endpoint
17 Aug 2023 //
PR NEWSWIRE
FDA allows more imports of key cancer med from China`s Qilu
13 Jul 2023 //
FIERCE PHARMA
FDA to import more of cancer drug from China
12 Jul 2023 //
ENDPTS
Qilu Announces Trials in Progress Posters on QL1706 in Phase III
08 Jun 2023 //
PR NEWSWIRE
Advances of Qilu Pharmaceutical`s QL1706 in Clinical Research Presented at ASCO
31 May 2023 //
PR NEWSWIRE
Qilu Pharma Latest Results of QL1604 plus Chemotherapy as First-Line Treatment
05 Dec 2022 //
BIOSPACE
CellOrigin Announces Collaboration with Qilu to Develop CAR-iMAC Cell Therapy
26 Sep 2022 //
PRNEWSWIRE
CellOrigin announced collaboration with Qilu to develop CAR-iMAC cell therapy
06 Sep 2022 //
WFMZ
S. Korea`s Peptron licenses global development of ADCs for cancer treatment
19 Apr 2021 //
BIOSPECTRUMASIA
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 //
PRNEWSWIRE
Sesen Bio and Qilu Pharmaceutical Announce Approval of IND Application Vicineum™
22 Mar 2021 //
BUSINESSWIRE
Cend Therapeutics and Qilu Pharmaceutical Announce Partnership
16 Feb 2021 //
GLOBENEWSWIRE
Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™
13 Jan 2021 //
BUSINESSWIRE
Sesen Bio and Qilu Announce IND Application for Vicineum™
13 Jan 2021 //
BUSINESSWIRE
Sesen Bio announces an exclusive license agreement with Qilu Pharma
30 Jul 2020 //
BUSINESSWIRE
Indian generics contenders; Chi-Med`s HK listing; Qilu Pharma explosion
20 Apr 2019 //
FIERCE PHARMA
Camptosar ANDA Approval Adds More Competition for Generic Market
09 May 2016 //
TWOFOUR INSIGHT
China`s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts
09 Mar 2016 //
BLOOMBERG
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.